TSH may not be a good marker for adequate thyroid hormone replacement therapy

Wiener Klinische Wochenschrift

Volumn 117, Issue 18, 2005, Pages 636-640

  Alevizaki, Maria ^a,c   Mantzou, Emily ^a   Cimponeriu, Adriana T ^a   Alevizaki, Calliope C ^b   Koutras, Dimitri A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c ALEXANDRA HOSPITAL   (Greece)

Author keywords

Hypothyroidism; Replacement treatment; SHBG; Thiodothyronine; Thyroxine

Indexed keywords

LIOTHYRONINE; SEX HORMONE BINDING GLOBULIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

BIOLOGICAL MARKERS; FEMALE; GREECE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 27144492734     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0421-0     Document Type: Article

References (32)

1. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH (1990) American Thyroid Association guidelines for use of laboratory tests in thyroid diseases. JAMA 263: 1529-1532
2. Saravanan P, Chau W-F, Roberts N, Vedhara K, Greenwood R, Dayan CM (2002) Psychological well-being in patients on "adquate" doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol 57: 577-585
3. Romijn JA, Smit JWA, Lamberts SW (2003) Intrinsic imperfections of endocrine replacement therapy. Eur J Endocrinol 149: 91-97
4. Larsen PR (1982) Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 306: 23-32
5. Koutras DA, Malamitsi J, Souvatzoglou A. Piperimgos GD, Livadas DP, Boukis M, Papachristou DN, Sfontouris J, Moulopoulos SD (1981) Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent. J Endocrinol Invest 4: 343-347
6. Demers LM, Spencer CA (2003) Thyrotropin measurements. In: Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13: 33-44
7. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002) Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489-499
8. Pallas D, Koutras DA, Adamopoulos P, Marafelia P, Souvatzoglou A, Piperingos GD, Moulopoulos SD (1991) Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism? J Endocrinol Invest 14: 743-746
9. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamatelopoulos S, Koutras DA (1997) Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7: 411-414
10. Andersen S, Pedersen KM, Bruun NH, Laurberg P (2002) Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87: 1068-1072
11. Hampl R, Kancheva R, Hill M, Bicikova M, Vondra K (2003) Interpretation of SHBG levels in thyroid disorders. Thyroid 13: 755-760
12. Larsen PR, Dick TE, Markovitz BP, Kaplan MM, Gard TG (1979) Inhibition of intrapituitary thyroxine to 3.5.3′-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest 64: 117-128
13. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ (1999) Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340: 424-429
14. Reichlin S, Utiger RD (1967) Regulation of the pituitarythyroid axis in man: relationship of TSH to concentration of free and total thyroxine in plasma. Clin Endocrinol 27: 251-255
15. Koutras DA (1992) Thyroxine therapy: benefits and risks. In: Nice Mornex R, Jaffiol C, Leclere J (eds) Progress in endocrinology. The Proceedings of the Ninth International Congress of Endocrinology. Parthenon Publishing Group Lanes UK and NY, USA, pp 293-298
16. Meier C, Trittibach P, Guglielmetti M, Staub J-J, Müller B (2003) Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey. BMJ 326: 311-312
17. Woeber KA (2002) Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest 25: 106-109
18. St Germain DL, Gaton VA (1997) The deiodinase family of selenoproteins. Thyroid 7: 655-668
19. Escobar-Morreale HF, del Ray FE, Obregon MJ, de Escobar GM (1996) Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 137: 2490-2502
20. Clyde PW, Harari AE, Getka EJ, Shakir KM (2003) Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 290: 2952-2958
21. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC, Cussons AJ (2003) Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88: 4543-4550
22. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT (2003) Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88: 4551-4555
23. Kaplan MM, Same DH, Schneider AB (2003) In search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. J Clin Endocrinol Metab 88: 4540-4542
24. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP (2004) Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 14: 271-275
25. Vanderpump MP, Ahlquist JA, Frankly n JA, Clayton RN (1996) Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 313: 539-544
26. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249-1252
27. Toft AD (2001) Subclinical hyperthyroidism. N Engl J Med 345: 512-516
28. Franklyn JA, Betteridge J, Daykin J, Holder R, Gates GD, Parle JV, Lilley J, Heath DA, Sheppard MC (1992) Longterm thyroxine treatment and bone mineral density. Lancet 340: 9-13
29. Weissel M (2001) Hyperthryroidism and heart. Wien Klin Wochenschr 113: 157-161
30. Toft AD, Beckett GJ (2003) Thyroid function tests and hypothyroidism. BMJ 326: 295-296
31. Hennemann G, Krenning EP (2003) Editorial. Report of the 74th Annual Meeting of the American Thyroid Association, Thyroid International. Merck KGaA, Darmstadt, Germany, 1: 8-10
32. Carr D, McLeod DT, Parry G, Thornes HM (1988) Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurements of free thyroid hormones and clinical assessment. Clin Endocrinol 28: 325-333